Cargando…

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer

Detalles Bibliográficos
Autores principales:	Deniger, Drew C, Bharathan, Mini, Anna, Pasetto, Tran, Eric, Gartner, Jared J, Prickett, Todd D, Robbins, Paul F, Rosenberg, Steven A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645482/ http://dx.doi.org/10.1186/2051-1426-3-S2-P10

Ejemplares similares

Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers
por: Bharathan, Mini, et al.
Publicado: (2015)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
por: Parkhurst, Maria, et al.
Publicado: (2015)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms
por: Trebska-Mcgowan, Kasia, et al.
Publicado: (2015)

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
por: Stevanović, Sanja, et al.
Publicado: (2015)

High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
por: Anna, Pasetto, et al.
Publicado: (2015)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients
por: Cohen, Cyrille, et al.
Publicado: (2015)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma
por: Beane, Joal D, et al.
Publicado: (2014)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
por: Cafri, Gal, et al.
Publicado: (2019)

Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma
por: White, Bradley Sinclair, et al.
Publicado: (2023)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2013)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
por: Sarnaik, Amod, et al.
Publicado: (2015)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Isolation of T cell receptors specifically reactive with mutated tumor associated antigens
por: Parkhurst, Maria, et al.
Publicado: (2014)

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
por: Haymaker, Cara, et al.
Publicado: (2015)

Characterization and quantification of tumor infiltrating lymphocytes in breast cancer
por: Bedri, Shahinaz, et al.
Publicado: (2014)

Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients
por: Chen, Wan-Yu, et al.
Publicado: (2014)

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma
por: Hall, MacLean, et al.
Publicado: (2015)

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes
por: Galetta, Henry, et al.
Publicado: (2015)

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
por: Donia, Marco, et al.
Publicado: (2015)

Toward cell transfer immunotherapy against patient-specific mutations in gastrointestinal cancers
por: Tran, Eric, et al.
Publicado: (2014)

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
por: Leko, Vid, et al.
Publicado: (2021)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
por: Meng, Qingda, et al.
Publicado: (2014)

Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
por: Kishi, Hiroyuki, et al.
Publicado: (2015)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
por: Lu, Yong-Chen, et al.
Publicado: (2021)

Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
por: Poschke, Isabel, et al.
Publicado: (2015)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
por: Nguyen, Linh T, et al.
Publicado: (2013)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013)

Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade
por: Pilones, Karsten, et al.
Publicado: (2014)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
por: Turksma, Annelies, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ied95oke5l8brnofm5gul6rnc1